Answer
Hair loss is commonly reported during pertuzumab-containing treatment, but accompanying chemotherapy is often an important cause.
Sources for this answer
- Perjeta 420 mg Concentrate for Solution for Infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.